Early detection and treatment of rare heart muscle diseases
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at people who have been newly diagnosed with heart failure to find rare forms of heart muscle disease (cardiomyopathy) early and start the right treatment. It uses advanced heart imaging (CMR) and requires that you have not had heart problems before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have heart failure that has just been found, and your doctor is planning to start you on heart medications.
- You have no known history of heart disease, including blocked arteries, valve problems, or heart muscle damage.
- Your kidney function is good (creatinine clearance at least 50 ml/min).
- Your heart's pumping ability is normal or nearly normal (LVEF 50% or higher).
- You agree to have a special MRI of your heart (CMR) and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special CT scan to create a 3D model of your heart's blood flow. It aims to see if this model can help doctors better predict how well treatments work for people with a thick heart muscle that blocks blood flow.
This study looks at how small blood vessels in the heart affect outcomes in people with dilated cardiomyopathy (an enlarged, weak heart). You may qualify if you have heart failure with a weak pump and no significant blockages in your main heart arteries.
This study follows patients with HCM (a condition where the heart muscle becomes abnormally thick) to understand how the disease affects them over time in everyday life. The goal is to learn more about treatment outcomes and quality of life for people living with this condition.
This study is looking at people with cardiomyopathy to understand which patients are most in need of a heart transplant. By joining, you will help doctors learn more about critical cases and improve care for heart muscle disease.
This study looks at whether certain antibodies (proteins in your blood) can help predict how dilated cardiomyopathy will progress. By testing your blood, researchers hope to learn more about your condition and find better ways to manage it.
This study uses MRI scans to re-examine people with hypertrophic cardiomyopathy (a thickening of the heart muscle) who were part of the original HCMR study. It compares different types of HCM to learn more over time.
Hear when a new Hypertrophic Cardiomyopathy (HCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.